학술논문
Continued Five-Alpha Reductase Inhibitor Use After Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the Canary Prostate Active Surveillance Study (PASS)
Document Type
Article
Author
Source
In The Journal of Urology July 2018
Subject
Language
ISSN
0022-5347